title: Lamivudine treatment for children with interferon refractory chronic hepatitis B.
authors.forename: N
authors.initials: N
authors.lastname: Koçak
authors.forename: I N
authors.initials: IN
authors.lastname: Saltik
authors.forename: H
authors.initials: H
authors.lastname: Ozen
authors.lastname: Yüce
authors.forename: F
authors.initials: F
authors.lastname: Gürakan
mesh_terms: D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004351:Drug Resistance; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D019233:Retreatment; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine